within Pharmacolibrary.Drugs.ATC.V;

model V10AX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0002 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,
    adminCount     = 1,
    Vd             = 1.4999999999999999e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Rhenium (186Re) sulfide colloid is a radioactive therapeutic agent used primarily for radionuclide synovectomy to treat chronic inflammatory joint diseases such as rheumatoid arthritis. It is administered intra-articularly, delivering localized radiation to inflamed synovial tissue. It is used in some countries for radiosynovectomy procedures, but is not approved as a drug in all jurisdictions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult patients receiving intra-articular injection for synovectomy. No published population PK models or comprehensive pharmacokinetic data specific to this colloid could be found.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V10AX05;
